SARS-CoV-2 and probable lung cancer risk

The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed details regarding the long-term complications and po...

Full description

Saved in:
Bibliographic Details
Published in:Bioimpacts 2022-01, Vol.12 (3), p.291-292
Main Authors: Khiali, Sajad, Rezagholizadeh, Afra, Entezari-Maleki, Taher
Format: Article
Language:English
Subjects:
ACE2
Angiogenesis
Angiotensin
Angiotensin-converting enzyme 2
Carcinogenesis
Cell growth
Chronic infection
Coronaviruses
COVID-19
Cytokine storm
Cytokines
Developmental stages
Enzymes
Fibrosis
Infections
Inflammation
Lung cancer
Lung carcinoma
Lung diseases
lung fibrosis
Middle East respiratory syndrome
Non-small cell lung carcinoma
oncovirus
Pathogenesis
Peptidyl-dipeptidase A
Public health
Pulmonary fibrosis
Respiratory diseases
Risk factors
sars-cov-2
Severe acute respiratory syndrome coronavirus 2
Small cell lung carcinoma
Tumor necrosis factor-TNF
Tumorigenesis
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed details regarding the long-term complications and post-infection immunity of the coronavirus disease 2019 (COVID-19). Based on pathophysiological features, SARS-CoV-2 may act similarly as an oncovirus in the lung. This letter summarized three possible oncogenic mechanisms of SARS-CoV-2 that may be associated with lung cancer development.
ISSN:2228-5660
2228-5652
2228-5660
DOI:10.34172/bi.2022.23266